Table 20.
Country | N | GEN | CHL | AMP | CTX | CAZ | MEM | TGC | NAL | CIP | AZM | COL | SMX | TMP | TET |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyprusa | 1 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
Czech Republica | 4 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
Irelanda | 5 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 |
Malta | 36 | 61.1 | 0 | 72.2 | 2.8 | 0 | 0 | 0 | 69.4 | 69.4 | 0 | 0 | 77.8 | 2.8 | 61.1 |
Portugala | 1 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
Romania | 12 | 91.7 | 0 | 91.7 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 33.3 | 100 | 0 | 100 |
Spain | 19 | 84.2 | 0 | 73.7 | 0 | 0 | 0 | 0 | 94.7 | 94.7 | 0 | 0 | 84.2 | 0 | 63.2 |
United Kingdoma | 1 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
Total (8 MSs) | 79 | 70.9 | 0 | 74.7 | 1.3 | 0 | 0 | 0 | 78.5 | 78.5 | 0 | 5.1 | 81 | 1.3 | 67.1 |
ECOFFs: epidemiological cut‐off values; EUCAST: European Committee on Antimicrobial Susceptibility Testing; N: number of isolates tested; MSs: Member States; GEN: gentamicin; CHL: chloramphenicol; AMP: ampicillin; CTX: cefotaxime; CAZ: Ceftazidime; MEM: meropenem; TGC: tigecycline; NAL: nalidixic acid; CIP: ciprofloxacin; AZM: azithromycin; COL: colistin; SMX: sulfamethoxazole; TMP: trimethoprim; TET: tetracycline.
The occurrence of resistance is assessed on less than 10 isolates and should only be considered as part of the total from all MSs data.